Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > J Korean Cancer Assoc > Volume 32(2); 2000 > Article
Original Article
Proteolytic Regulation of Retinoblastoma Family Protein p107 by Ubiquitin - proteasome Pathway
J S Jang, B K Park, S G Hwang
Journal of the Korean Cancer Association 2000;32(2): 417-421.
  • 2,119 Views
  • 16 Download
  • 0 Crossref
  • 0 Scopus
prev next

PURPOSE
Proteolysis is an important way to regulate cell cycle regulatory proteins. Ubiquitin- proteasome pathway regards as highly selective proteolytic machinary mostly in physiological state. We investigated the role of ubiquitin-proteasome pathway in p107 protein degradation.
MATERIALS AND METHODS
p107 protein level was determined by western blot analysis in Ewings sarcoma cell line incubated with HMG-CoA inhibitor lovastatin. Recovery of p107 protein was determined with inhibitors of proteasome, serine protease or caspase. Ubiquitination of p107 protein was assessed by ubiquitin western analysis.
RESULTS
pl07 protein level was decreased with lovastin and its proteolytic effect was counteracted with proteasome inhibitors. Ubiquitin western analysis showed p107 protein fragments were tagged with ubiquitin and it was more evident with specific proteasome inhibitor lactacystin.
CONCLUSION
Lovastatin drives p107 protein to be degraded. In a certain circumstance proteolysis of p107 protein was executed by ubiquitin-proteasome pathway.

  • Cite
    CITE
    export Copy Download
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Proteolytic Regulation of Retinoblastoma Family Protein p107 by Ubiquitin - proteasome Pathway
    J Korean Cancer Assoc. 2000;32(2):417-421.
    Close

Cancer Res Treat : Journal of the Korean Cancer Association
Close layer
TOP